Navigation Links
Endo Pharmaceuticals Reports Strong Fourth Quarter and Full-Year 2009 Financial Results: Provides 2010 Financial Guidance
Date:2/22/2010

d statements of operations: (1) To exclude amortization of commercial intangible assets related to marketed products. (2) To exclude separation costs of $10,459, impairment of long-lived assets of $1,482 and contract termination costs of $540. (3) To exclude upfront and milestone payments to partners of $8,910, separation costs of $825, impairment of long lived assets of $3,115 and contract termination costs of $4,551. (4) To exclude impairment of other intangibles. (5) To exclude purchased in-process research and development. (6) To exclude additional interest expense as a result of adopting ASC 470-20. (7) To exclude changes in fair value of financial instruments, net. (8) To reflect the tax effect of the pre-tax adjustments above at the applicable tax rates. For an explanation of Endo's reasons for using non-GAAP measures, see Endo's Current Report on Form 8-K filed today with the Securities and Exchange Commission. Reconciliation of Projected GAAP Diluted Earnings Per Share to Adjusted Diluted Earnings Per Share Guidance Year Ending Dec. 31, 2010 Projected GAAP diluted income per common share $2.40 To $2.45 Upfront and milestone payments to partners $0.12 $0.12 Amortization of commercial intangible assets $0.59 $0.59 Interest expense adjustment for ASC 470-20 and the amortization of the premium on debt acquired from Indevus $0.15 $0.15 Tax effect of pre-tax adjustments at the applicable tax rates and certain other expected cash tax savings as a result of the Indevus acquisition ($0.11) ($0.11) Diluted adjusted income pe
'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 2015 A power morcellator lawsuit ( http://www.morcellatorlawsuit2015.com ... for an undisclosed amount, Bernstein Liebhard LLP reports. According ... 2014 in the U.S. District Court, Eastern District of ... widower whose wife had died in February 2013, just ... involved the use of a power morcellator. Following the ...
(Date:7/7/2015)... Juli 2015 Sequent Medical, ein ... Entwicklung innovativer Geräte für die Behandlung neurovaskulärer ... von R. Michael Kleine in den ... verfügt über eine mehr als 25-jährige Erfahrung ... hat verschiedene globale biomedizinische Unternehmen erfolgreich geleitet ...
(Date:7/7/2015)... -- According to a new market research report ... Instrument), Application (Aerobic, Anaerobic, Yeast/ Fungi) & End User (Hospital, ... 2019", published by MarketsandMarkets, The global Blood Culture Tests Market ... Million in 2014 at a CAGR of 7.2% from 2014-2019. ... ma rket data T ables and ...
Breaking Medicine Technology:Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 2Lina Medical, Power Morcellator Lawsuit Plaintiff Reach Settlement in Case Scheduled for November Trial, Bernstein Liebhard LLP Reports 3Sequent Medical beruft Mike Kleine in den Aufsichtsrat 2Sequent Medical beruft Mike Kleine in den Aufsichtsrat 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 2Blood Culture Tests Market Worth $3,893.5 Million by 2019 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 4
... Boston Scientific Corporation (NYSE: BSX ) ... MADIT-CRT trial data in the current issue of the ... showed women received a greater clinical benefit from cardiac ... sub-analysis demonstrated that both men and women experienced significant ...
... CUPERTINO, Calif., Feb. 8, 2011 DURECT Corporation (Nasdaq: ... CreoSalus, Inc., has launched commercial sales of its Food ... Equine, an injectable animal health drug utilizing DURECT,s SABER™ ... a royalty on net sales of SucroMate and will ...
Cached Medicine Technology:Boston Scientific Welcomes Publication of Gender Data Highlighting Benefits Women Receive From CRT-Ds 2Boston Scientific Welcomes Publication of Gender Data Highlighting Benefits Women Receive From CRT-Ds 3Boston Scientific Welcomes Publication of Gender Data Highlighting Benefits Women Receive From CRT-Ds 4DURECT Announces Launch of First FDA Approved SABER™-Injectable Peptide Product 2DURECT Announces Launch of First FDA Approved SABER™-Injectable Peptide Product 3
(Date:7/7/2015)... and CHICAGO (PRWEB) , ... July 07, 2015 ... ... healthcare business development and growth strategy expert Jay Warden as Senior Vice President, ... for the company’s efforts to provide the best solutions to healthcare providers’ needs ...
(Date:7/7/2015)... ... July 07, 2015 , ... More than ... Dial and Howdy’s, raised more than $524,286 during the Muscular Dystrophy Association's ... $100,000, to help support children fighting muscular dystrophy and related life-threatening diseases ...
(Date:7/7/2015)... York, NY (PRWEB) , ... July 07, 2015 , ... ... thing that can help pass those long, stressful days at work is knowing that ... aren’t always as laid back and stress free as imagined. Planning for a vacation ...
(Date:7/7/2015)... ... July 07, 2015 , ... This week Northeast Nebraska Imaging, ... website. The website’s goal is to provide patients with detailed information about the ... requesting appointments online. , Part of the center’s rebranding efforts, the website was ...
(Date:7/7/2015)... ... July 07, 2015 , ... Seattle-based ... have merged to form Camber Collective. Camber Collective provides strategic advisory services ... SwitchPoint’s strategy consulting expertise with Hope Consulting’s deep experience in customer insights, ...
Breaking Medicine News(10 mins):Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2
... N.C., Jan. 29 In today,s volatile ... unwary,pharmaceutical company and nullify product forecasts, sales ... on competitors,products and operations, a high-functioning Competitive ... opportunities as well as warn,them about potential ...
... Collaboration with Harvard Medical International Provides ... Vital Global Health Information, BALTIMORE, Jan. 29 ... reach of their groundbreaking MEDEX,360m partnership with the launch ... and leisure travelers., Like the original MEDEX 360m ...
... that it takes 50,000 lying side by side to equal ... to be highly accurate vehicles for administering medicines and other ... what happens to the tubes after they discharge their medical ... Now, Stanford researchers, who spent months tracking the tiny tubes ...
... an in utero stem cell treatment could lead to ... as a range of other disabling,conditions, according to a ... (UQ). , Action Medical Research has announced the outcomes ... led by Professor Nicholas Fisk, that could lead to ...
... of DNA in the human genome that originated from ... bodies and are even essential for a healthy pregnancy, ... Microbiology Today. , Retrovirus infections represent the most intimate ... genome into the DNA of the host cell, resulting ...
... security, reduces risk and ... supports ... global,provider of integrated security, risk and audit management solutions, today,announced ... Service (NHS) has selected its flagship SecureVue(R) platform to,proactively manage ...
Cached Medicine News:Health News:Building and Sustaining Impactful Competitive Intelligence Organizations for Pharma 2Health News:MEDEX / Harvard Partnership Now Offers Affordable, New Intelligence to Individual Business & Leisure Travelers 2Health News:New nanotube findings by Stanford researchers give boost to potential biomedical applications 2Health News:New nanotube findings by Stanford researchers give boost to potential biomedical applications 3Health News:Stem cell treatment for brittle bones in the womb 2Health News:The North Western Deanery of UK's National Health Service Selects eIQnetworks' SecureVue for Comprehensive IT Assurance 2Health News:The North Western Deanery of UK's National Health Service Selects eIQnetworks' SecureVue for Comprehensive IT Assurance 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: